62 related articles for article (PubMed ID: 31975504)
1. MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
Wang C; Uemura M; Tomiyama E; Matsushita M; Koh Y; Nakano K; Hayashi Y; Ishizuya Y; Jingushi K; Kato T; Hatano K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Tsujikawa K; Nonomura N
Cancer Sci; 2020 Apr; 111(4):1146-1155. PubMed ID: 31975504
[TBL] [Abstract][Full Text] [Related]
2. miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2.
Gao Y; Ma X; Yao Y; Li H; Fan Y; Zhang Y; Zhao C; Wang L; Ma M; Lei Z; Zhang X
Oncotarget; 2016 Apr; 7(15):20324-37. PubMed ID: 26967247
[TBL] [Abstract][Full Text] [Related]
3. miRNA-27b-3p/TPX2 Axis Regulates Clear Cell Renal Cell Carcinoma Cell Proliferation, Invasion and Migration.
Liu N; Jiang Y; Chen S; Pan F; Tang Y; Tan X
Crit Rev Eukaryot Gene Expr; 2024; 34(1):27-39. PubMed ID: 37824390
[TBL] [Abstract][Full Text] [Related]
4. microRNA-92b-3p augments colon cancer development through inhibiting KLF3.
Liu X; Zhang L
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23488. PubMed ID: 37597242
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.
Gao S; Wang Z
J Healthc Eng; 2021; 2021():3533608. PubMed ID: 34221297
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-92b-3p Targeting FHL2 to Enhance Radiosensitivity of Nasopharyngeal Carcinoma.
Zeng C; Duan S; Zhao L; Jiang J
Biochem Genet; 2024 Mar; ():. PubMed ID: 38512583
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.
Pichler M; Stiegelbauer V; Vychytilova-Faltejskova P; Ivan C; Ling H; Winter E; Zhang X; Goblirsch M; Wulf-Goldenberg A; Ohtsuka M; Haybaeck J; Svoboda M; Okugawa Y; Gerger A; Hoefler G; Goel A; Slaby O; Calin GA
Clin Cancer Res; 2017 Mar; 23(5):1323-1333. PubMed ID: 27601590
[No Abstract] [Full Text] [Related]
8. Large-scale genome-wide screening of circulating microRNAs in clear cell renal cell carcinoma reveals specific signatures in late-stage disease.
Chanudet E; Wozniak MB; Bouaoun L; Byrnes G; Mukeriya A; Zaridze D; Brennan P; Muller DC; Scelo G
Int J Cancer; 2017 Nov; 141(9):1730-1740. PubMed ID: 28639257
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92b in the skeletal muscle regulates exercise capacity via modulation of glucose metabolism.
Yang S; Yang G; Wang X; Li L; Li Y; Xiang J; Kang L; Liang Z
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2925-2938. PubMed ID: 37985354
[TBL] [Abstract][Full Text] [Related]
10. miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma.
Ran L; Liang J; Deng X; Wu J
Biomed Res Int; 2017; 2017():4832931. PubMed ID: 29392135
[TBL] [Abstract][Full Text] [Related]
11. miR-92b ameliorates lipoteichoic acid induced endometritis by suppressing Wnt/β-catenin pathway activation.
Zheng Z; Guo Y; Zheng Y; Wu H
Theriogenology; 2024 Jan; 214():307-313. PubMed ID: 37956579
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis.
Le LN; Choi C; Han JA; Kim EB; Trinh VN; Kim YJ; Ryu S
Front Oncol; 2024; 14():1371934. PubMed ID: 38680858
[TBL] [Abstract][Full Text] [Related]
13. Retracted: miR-92b-3p Exerts Neuroprotective Effects on Ischemia/Reperfusion-Induced Cerebral Injury via Targeting NOX4 in a Rat Model.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9805456. PubMed ID: 38189002
[TBL] [Abstract][Full Text] [Related]
14. Retraction: RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7.
Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38516709
[No Abstract] [Full Text] [Related]
15. The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers.
Ayed A
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38691151
[TBL] [Abstract][Full Text] [Related]
16. MircroRNA-92b as a negative regulator of the TGF-β signaling by targeting the type I receptor.
Yang S; Jiang K; Li L; Xiang J; Li Y; Kang L; Yang G; Liang Z
iScience; 2023 Nov; 26(11):108131. PubMed ID: 37867958
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow fatty acids affect osteoblastic differentiation through miR-92b-3p in the early stages of postmenopausal osteoporosis.
Wang S; Tang C; Chen J; Tang H; Zhang L; Tang G
Heliyon; 2023 Jun; 9(6):e16513. PubMed ID: 37274695
[TBL] [Abstract][Full Text] [Related]
18. A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma.
Piao Y; Jung SN; Lim MA; Oh C; Jin YL; Kim HJ; Nguyen QK; Chang JW; Won HR; Koo BS
Sci Rep; 2023 Feb; 13(1):2000. PubMed ID: 36737651
[TBL] [Abstract][Full Text] [Related]
19. Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing.
Ochiai C; Miyauchi S; Kudo Y; Naruke Y; Yoneyama S; Tomita K; Dongze L; Chiba Y; Hirata TI; Ichijo T; Nagai K; Kobayashi S; Yamada S; Hikono H; Murakami K
PLoS One; 2021; 16(9):e0256588. PubMed ID: 34506539
[TBL] [Abstract][Full Text] [Related]
20. MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL.
Liang G; Ling Y; Lin Q; Shi Y; Luo Q; Cen Y; Mehrpour M; Hamai A; Li J; Gong C
Front Cell Dev Biol; 2021; 9():707049. PubMed ID: 34395434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
